Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group-Reference-Cited by-同舟云学术

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Published:2010-01 Issue:1 Volume:21 Page:114-119
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sperr W.R.,Wimazal F.,Kundi M.,Baumgartner C.,Nösslinger T.,Makrai A.,Stauder R.,Krieger O.,Pfeilstöcker M.,Valent P.

Funder

Tiroler Verein zur Förderung der Krebsforschung

Österreichische Krebshilfe-Krebsgesellschaft Tirol

Medizinischer Forschungsfonds Tirol

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/1/114/337195/mdp258.pdf

Reference40 articles.

1. Treatment and prognostic factors in myelodysplasic syndromes;Boogaerts;Bailliéres Clin Haematol,1996

2. Epidemiologic perspectives on myelodysplastic syndromes and leukemia;Cole;Leuk Res,1995

3. Prognostic factors and scoring systems in myelodysplastic syndromes;Sanz;Haematologica,1998

4. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference;Valent;Leuk Res,2007

5. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes;Germing;Ann Hematol,2008

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies;Cancers;2024-01-26

2. A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes;Journal of Clinical Medicine;2022-02-08

3. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5;Transplantation and Cellular Therapy;2021-11

4. Comorbidities and frailty predict outcome of patients with myelodysplastic syndromes. Should we integrate them in novel prognostic scoring systems?;Journal of Geriatric Oncology;2021-09

5. Predominant low Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) score in a Mexican referral center: a selection bias caused by limited-resources?;Hematology, Transfusion and Cell Therapy;2021-07